Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.93 |
| ▸ | TP53 | P04637 | 1/20 | 0.93 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.93 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.93 |
| ▸ | TSHR | P16473 | 1/20 | 0.93 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.93 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.93 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.93 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.93 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.92 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.81 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5304867 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5292464 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5289574 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5285514 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5307289 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5297463 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5818453 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5287604 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL22806629 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5290527 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312730-A1 | ACIDIC GAS ABSORBENTS COMPRISING IONIC LIQUIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2025-10-09 | — | — | US | disclosed |
| EP-4514528-A1 | ACIDIC GAS ABSORBENTS COMPRISING IONIC LIQUIDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2025-03-05 | — | — | EP | disclosed |
| WO-2023205851-A1 | ACIDIC GAS ABSORBENTS COMPRISING IONIC LIQUIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2023-11-02 | — | — | WO | disclosed |
| US-10888814-B2 | Removal of carbon dioxide from a gas stream by using aqueous ionic liquid | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2021-01-12 | — | — | US | disclosed |
| US-8734744-B2 | Separation of gases | PETROLIAM NASIONAL BERHAD (MY) | 2014-05-27 | — | — | US | disclosed |
| US-20130071309-A1 | SEPARATION OF GASES | PETROLIAM NASIONAL BERHAD (MY) | 2013-03-21 | — | — | US | disclosed |
| WO-2013037128-A1 | SEPARATION OF GASES | PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) | 2013-03-21 | — | — | WO | disclosed |
| US-20130058852-A1 | REMOVAL OF CARBON DIOXIDE FROM A GAS STREAM BY USING AQUEOUS IONIC LIQUID | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2013-03-07 | — | — | US | disclosed |
| WO-2011114168-A1 | REMOVAL OF CARBON DIOXIDE FROM A GAS STREAM BY USING AQUEOUS IONIC LIQUID | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2011-09-22 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071309-A1 | SEPARATION OF GASES | EPCAM, CA9, ALKBH2 | SLC22A1 1829/4885ALDH1A1 3075/4885TP53 253/4885 |
| US-20130058852-A1 | REMOVAL OF CARBON DIOXIDE FROM A GAS STREAM BY USING AQUEOUS IONIC LIQUID | CA2, CA9, CA4 | SLC22A1 81/4885ALDH1A1 3714/4885TP53 2264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.